Search hospitals
>
Ohio
>
Columbus
Ohio State University Comprehensive Cancer Center
Claim this profile
Columbus, Ohio 43210
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Pancreatic Cancer
806 reported clinical trials
145 medical researchers
Summary
Ohio State University Comprehensive Cancer Center is a medical facility located in Columbus, Ohio. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Breast cancer, Pancreatic Cancer and other specialties. Ohio State University Comprehensive Cancer Center is involved with conducting 806 clinical trials across 840 conditions. There are 145 research doctors associated with this hospital, such as Floor Backes, MD, Alice Mims, Uma Borate, MD, and Michael V Knopp, MD, PhD.
Area of expertise
Cancer
Ohio State University Comprehensive Cancer Center has run 149 trials for Cancer. Some of their research focus areas include:
Breast Cancer
Ohio State University Comprehensive Cancer Center has run 146 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Floor Backes, MD
Ohio State University Comprehensive Cancer Center
3 years of reported clinical research
Alice Mims
Ohio State University Comprehensive Cancer Center
6 years of reported clinical research
Uma Borate, MD
Ohio State University Comprehensive Cancer Center
4 years of reported clinical research
Michael V Knopp, MD, PhD
The Ohio State University Wexner Medical Center
3 years of reported clinical research
Clinical Trials running at Ohio State University Comprehensive Cancer Center
Breast Cancer
Lung Cancer
Breast cancer
Prostate Cancer
Skin Cancer
Pancreatic Cancer
Esophageal cancer
Cancer
Kidney Cancer
Chronic Lymphocytic Leukemia
Abemaciclib + Hormone Therapy
for Breast Cancer
This is a post-marketing single arm, phase IV trial in which patients with high-risk early-stage HR+HER2- breast cancer will receive adjuvant abemaciclib in combination with endocrine therapy (ET) After study intervention, participants will remain on combination abemaciclib + ET at the discretion of their treating providers
Recruiting
3 awards
Phase 4
5 criteria
Proton Craniospinal Radiation
for Cancer in the Brain and Spinal Cord
This phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has spread from where it first started to the cerebrospinal fluid filled space that surrounds the brain and spinal cord (leptomeningeal metastasis). Patients with leptomeningeal metastasis (LM) may develop multiple areas of nervous system (neurologic) impairment that can be life-threatening. Radiation therapy (RT) effectively relieves local symptoms due to LM. RT uses high energy radiography (x-rays), particles, or radioactive seeds to kill cancer cells and shrink tumors. IFRT is commonly used to treat symptoms of LM. IFRT is radiation treatment that uses x-rays to treat specific areas of LM and to relieve and/or prevent symptoms. pCSI uses protons that can be directed with more accuracy than x-rays which allows treatment of the entire central nervous system space containing the cerebrospinal fluid (CSF), brain, and spinal cord. The pCSI treatment could delay the worsening of LM. Giving pCSI may be better than IFRT in treating LM in patients with breast or non-small cell lung cancer.
Recruiting
2 awards
Phase 3
3 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting
2 awards
Phase 3
15 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Ohio State University Comprehensive Cancer Center?
Ohio State University Comprehensive Cancer Center is a medical facility located in Columbus, Ohio. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Breast cancer, Pancreatic Cancer and other specialties. Ohio State University Comprehensive Cancer Center is involved with conducting 806 clinical trials across 840 conditions. There are 145 research doctors associated with this hospital, such as Floor Backes, MD, Alice Mims, Uma Borate, MD, and Michael V Knopp, MD, PhD.
Where is Ohio State University Comprehensive Cancer Center located?
The Ohio State University Comprehensive Cancer Center is located at 300 West 10th Avenue, Columbus, OH 43210. For access, take Medical Center Drive to Dodd Drive, turn left, and follow signs to the Wexner Medical Center Garage. Alternatively, use Kinnear Road to King Avenue, turn left onto King, and then left onto Cannon Drive to reach the hospital.
Who should I call to ask about financial aid or insurance network?
**Ohio State University Comprehensive Cancer Center - Contact Information** - **Financial Counseling Department:** 614-293-0860 - **Financial Assistance:** 614-293-0860 - **Medication Assistance Program:** 614-293-3868 - **Patient Billing Customer Service:** 614-293-2100 - **Medicaid Assistance:** 614-293-0860, option 2 For more details or to apply for financial assistance, please visit the Financial Assistance page on our website.
What insurance does Ohio State University Comprehensive Cancer Center accept?
The Ohio State University Comprehensive Cancer Center (OSUCCC) accepts a wide range of insurance plans, including Medicaid, Medicare, and various exchange health plans. For Medicaid, accepted plans include AmeriHealth Caritas, Buckeye Community Health Plan, CareSource, Humana Healthy Horizons, and Medicaid Ohio Traditional. Medicare recipients are covered under all traditional plans and Medigap coverage, while exchange health plans accepted include CareSource Marketplace, Molina Healthcare of Ohio, and Buckeye AmBetter.
What awards or recognition has Ohio State University Comprehensive Cancer Center received?
The Ohio State University Comprehensive Cancer Center (OSUCCC) in Columbus, Ohio, has been a National Cancer Institute (NCI)-designated comprehensive cancer center since 1976, showcasing its commitment to excellence in research, patient care, education, and community outreach. It has garnered significant funding for research and care, including NCI grants for phase 1, 2, and 3 clinical trials of novel cancer drugs. Additionally, the OSUCCC supports initiatives such as the Pelotonia Institute for Immuno-Oncology and the Center for Cancer Engineering.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.